Matt Riley | Head, IR |
Al Altomari | Chairman, CEO |
Dennis Reilly | CFO |
Oren Livnat | H.C. Wainwright |
Good afternoon, and welcome to the Agile Therapeutics’ First Quarter 2022 Financial Results Conference Call. Please note, today's event is being recorded. I would now like to turn the conference over to Matt Riley, Head of Investors Relations.
Hello, everyone. And welcome to today’s conference call to discuss our first quarter 2022 financial results and corporate update.